Mumps Vaccine, Live (Wuhan Institute Of Biological Products)

腮腺炎减毒活疫苗（武汉生物制品研究所）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMumps Vaccine, Live (Wuhan Institute Of Biological Products)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II)

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsParotitis

Global Approved IndicationsParotitis

Approved Indications in ChinaParotitis

Original Approved Country/TerritoryMainland China

Original Approved Date1994/01/01

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaApproved

Originator CompaniesWuhan Institute Of Biological Products Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesWuhan Institute Of Biological Products Co Ltd

Inactive CompaniesN/A

Active IndicationsParotitis

Inactive IndicationsN/A

Other Information

ATC CodeJ07BE01